|
|
| Zeile 3: |
Zeile 3: |
| | *[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187738/?report=classic big link list published as a paper] | | *[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187738/?report=classic big link list published as a paper] |
| | *'''[[Unproven ideas]]''' | | *'''[[Unproven ideas]]''' |
| − | *'''[[Reviews on covid19 disease]]'''} | + | *'''[[Reviews on covid19 disease]]''' |
| − | {{tp|p=32388326|t=2020. Role of increasing the aerobic capacity on improving the function of immune and respiratory systems in patients with coronavirus (COVID-19): A review |pdf=|usr=}}
| + | |
| − | {{tp|p=32382706|t=ä. Emergent materials and industry 4 0 contribution toward pandemic diseases such as COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=30872283|t=2019. Slicing and dicing viruses: antiviral RNA interference in mammals |pdf=|usr=}}
| + | |
| − | {{tp|p=32312863|t=2020. Short-term outcomes of COVID-19 and risk factors for progression |pdf=|usr=}}
| + | |
| − | {{tp|p=32217658|t=ä. Strategies for the prevention and management of coronavirus disease 2019 |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| Zeile 34: |
Zeile 29: |
| | | | |
| | *'''[[Diagnosis (Lung CT, Sonography)]]''' | | *'''[[Diagnosis (Lung CT, Sonography)]]''' |
| − | {{tp|p=32375883|t=2020. Can computed tomography be a primary tool for COVID-19 detection? Evidence appraisal through meta-analysis |pdf=|usr=}}
| |
| − | {{tp|p=32378021|t=ä. Tracheobronchitis signs observed on ventilation lung scintigraphy during the course of COVID-19 infection |pdf=|usr=}}
| |
| − | {{tp|p=32408222|t=2020. Deep learning-based multi-view fusion model for screening 2019 novel coronavirus pneumonia: A multicentre study |pdf=|usr=}}
| |
| − | {{tp|p=32387924|t=2020. Early CT features and temporal lung changes in COVID-19 pneumonia in Wuhan, China |pdf=|usr=}}
| |
| − | {{tp|p=32060619|t=ä. Imaging features of 2019 novel coronavirus pneumonia |pdf=|usr=}}
| |
| − | {{tp|p=32139463|t=2020. High-resolution computed tomography features of 17 cases of coronavirus disease 2019 in Sichuan province, China |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | | | |
| Zeile 68: |
Zeile 56: |
| | | | |
| | *'''[[Immunology]]''' | | *'''[[Immunology]]''' |
| − | {{tp|p=32200654|t=2020. Time Kinetics of Viral Clearance and Resolution of Symptoms in Novel Coronavirus Infection |pdf=|usr=}}
| |
| − | {{tp|p=32361250|t=2020. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients |pdf=|usr=}}
| |
| | | | |
| | *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' | | *'''[[Cytokine storm, hemophagocytic lymphohistiocytosis, macrophage activation syndrome]]''' |
| − | {{tp|p=32387470|t=2020. COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?|pdf=|usr=}}
| |
| − | {{ttp|p=32418715|t=ä. COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons |pdf=|usr=}}
| |
| − | {{tp|p=32388462|t=2020. A glimpse into the eye of the COVID-19 cytokine storm |pdf=|usr=}}
| |
| − | {{ttp|p=27925643|t=2017. Primary and secondary hemophagocytic lymphohistiocytosis have different patterns of T?cell activation, differentiation and repertoire |pdf=|usr=}}
| |
| | | | |
| | | | |
| Zeile 90: |
Zeile 72: |
| | | | |
| | *'''[[Similar diseases and pathomechanisms]]''' | | *'''[[Similar diseases and pathomechanisms]]''' |
| − | {{tp|p=32402576|t=ä. Oxidative Stress as Key Player in Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection |pdf=|usr=}}
| |
| − | {{tp|p=25421478|t=2015. Biochemical Characterization of Recombinant Enterovirus 71 3C Protease with Fluorogenic Model Peptide Substrates and Development of a Biochemical Assay |pdf=|usr=}}
| |
| − | {{tp|p=24995382|t=2014. Accessory proteins of SARS-CoV and other coronaviruses |pdf=|usr=}}
| |
| − | {{ttp|p=23607598|t=2013. Involvement of high mobility group box 1 and the therapeutic effect of recombinant thrombomodulin in a mouse model of severe acute respiratory distress syndrome |pdf=|usr=}}
| |
| − | {{tp|p=30461192|t=2019. Toward development of generic inhibitors against the 3C proteases of picornaviruses |pdf=|usr=}}
| |
| − |
| |
| | *'''[[Early symptoms]]''' | | *'''[[Early symptoms]]''' |
| | | | |
| Zeile 104: |
Zeile 80: |
| | | | |
| | *'''[[Pulmonary embolism, coagulation]]''' | | *'''[[Pulmonary embolism, coagulation]]''' |
| − | {{tp|p=32418867|t=ä. COVID-19 associated coagulopathy: The crowning glory of thrombo-inflammation concept |pdf=|usr=}}
| |
| − | {{tp|p=C7196387|t=ä. Extensive aortic thrombosis in a patient with Covid-19 |pdf=|usr=}}
| |
| − | {{tp|p=32386987|t=ä. Tromboembolia pulmonar aguda y enfermedad por coronavirus (COVID-19): �una asociaci�n frecuente en pacientes graves?|pdf=|usr=}}
| |
| − | {{tp|p=32414639|t=ä. Bleeding in COVID-19 severe pneumonia: The other side of abnormal coagulation pattern?|pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| | *'''[[Hematology]]''' | | *'''[[Hematology]]''' |
| | | | |
| Zeile 156: |
Zeile 125: |
| | | | |
| | *'''[[Risk and special populations]]''' | | *'''[[Risk and special populations]]''' |
| − | {{tp|p=32408118|t=2020. Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis |pdf=|usr=}}
| |
| − | {{tp|p=32387864|t=2020. SARS-CoV-2 infection and obesity: Common inflammatory and metabolic aspects |pdf=|usr=}}
| |
| − | {{tp|p=32388171|t=2020. SARS-COV-2 infection in patients with cancer undergoing checkpoint blockade: Clinical course and outcome |pdf=|usr=}}
| |
| − | {{tp|p=32291196|t=2020. Is low sodium intake a risk factor for severe and fatal COVID-19 infection?|pdf=|usr=}}
| |
| − | {{tp|p=32402627|t=ä. Re: Novel Coronavirus COVID-19 in late pregnancy: Outcomes of first nine cases in an inner city London hospital |pdf=|usr=}}
| |
| − | {{tp|p=32389521|t=2020. COVID-19 infection in patients following hepato-pancreatico-biliary intervention: An early experience |pdf=|usr=}}
| |
| − | {{tp|p=32409114|t=ä. Clinical Course, Imaging Features, and Outcomes of COVID-19 in Kidney Transplant Recipients |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | *'''[[Case reports]]''' | | *'''[[Case reports]]''' |
| Zeile 172: |
Zeile 133: |
| | | | |
| | *'''[[Case series]]''' | | *'''[[Case series]]''' |
| − | {{tp|p=C7165248|t=2020. Auch Kinder können schwer an COVID-19 erkranken |pdf=|usr=}}
| |
| − | {{tp|p=32408119|t=2020. COVID-19 outbreak in Iraqi Kurdistan: The first report characterizing epidemiological, clinical, laboratory, and radiological findings of the disease |pdf=|usr=}}
| |
| − | {{ttp|p=C7171478|t=2020. (Germany)The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDS |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | | | |
| Zeile 186: |
Zeile 143: |
| | | | |
| | *'''[[Candidate Compounds Covid19]]''' | | *'''[[Candidate Compounds Covid19]]''' |
| − | {{tp|p=32382358|t=ä. COVID-19 and Diabetes Mellitus: May Old Anti-diabetic Agents Become the New Philosopher?s Stone?|pdf=|usr=}}
| |
| − | {{tp|p=32377559|t=ä. COVID-19: Review of Epidemiology and Potential Treatments Against 2019 Novel Coronavirus |pdf=|usr=}}
| |
| − | {{tp|p=32387262|t=ä. Extracellular vesicles from mesenchymal stem cells as a Covid-19 treatment |pdf=|usr=}}
| |
| − | {{tp|p=C7194243|t=ä. Coronavirus Disease 2019 (COVID-19) Spread and Pharmacovigilance Implications: Expert Opinion |pdf=|usr=}}
| |
| − | {{tp|p=32383008|t=ä. The Role of Pharmacovigilance and ISoP During the Global COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32344202|t=2020. Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development |pdf=|usr=}}
| |
| − | {{tp|p=32387014|t=ä. Repositionnement de la chlorpromazine ... |pdf=|usr=}}''psychiatric patients could be protected from severe forms of COVID-19 by their psychotropic treatments''
| |
| − | {{tp|p=C7118608|t=ä. A Promising Anti-Cytokine-Storm Targeted Therapy for COVID-19: The Artificial-Liver Blood-Purification System |pdf=|usr=}}
| |
| − | {{tp|p=32292529|t=2020. Highlights of traditional Chinese medicine frontline expert advice in the China national guideline for COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32381323|t=ä. Acute hemolysis by hydroxycloroquine was observed in G6PD-deficient patient with severe COVD-19 related lung injury |pdf=|usr=}}
| |
| − | {{tp|p=C7117595|t=ä. Drug repurposing strategies for COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32348877|t=ä. Chemical evolution for taming the ?pathogenic kinase? PAK1 |pdf=|usr=}}
| |
| − | {{tp|p=16022774|t=2005. (+)SARS Vaccine Development |pdf=|usr=}}
| |
| − | {{tp|p=28861908|t=2017. (+)Issues in vaccinology: Present challenges and future directions |pdf=|usr=}}
| |
| − | {{tp|p=31931639|t=2020. Dapsone as treatment adjunct in ARDS |pdf=|usr=}}
| |
| − | {{tp|p=16433589|t=2006. (+)Antiviral applications of RNAi for coronavirus |pdf=|usr=}}
| |
| − | {{tp|p=32318055|t=2020. Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools |pdf=|usr=}}
| |
| | {{tp|p=32362826|t=2020. Editorial: New Advances in RNA Targeting |pdf=|usr=}} | | {{tp|p=32362826|t=2020. Editorial: New Advances in RNA Targeting |pdf=|usr=}} |
| | | | |
| Zeile 225: |
Zeile 165: |
| | | | |
| | *'''[[Running your hospital]]''' | | *'''[[Running your hospital]]''' |
| − | {{tp|p=32413820|t=2020. Social isolation during Covid-19: Boon or bane to diabetes management |pdf=|usr=}}
| |
| − | {{tp|p=32388333|t=2020. Internet of things (IoT) applications to fight against COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32386942|t=2020. Endoscopy during the Covid-19 outbreak: experience and recommendations from a single center in a high-incidence scenario |pdf=|usr=}}
| |
| − | {{tp|p=C7197607|t=ä. ISDE guidance statement: management of upper gastrointestinal endoscopy and surgery in COVID-19 outbreak |pdf=|usr=}}
| |
| − | {{tp|p=C7201032|t=2020. Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection |pdf=|usr=}}
| |
| − | {{tp|p=C7196409|t=ä. ...impact psychiatrique de la pandemie de covid-19 |pdf=|usr=}}
| |
| − | {{tp|p=32443202|t=2020. Disinfection technology of hospital wastes and wastewater: Suggestions for disinfection strategy during coronavirus Disease 2019 (COVID-19) pandemic in China |pdf=|usr=}}
| |
| − | {{tp|p=32387833|t=2020. Optimizing status epilepticus care during the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=C7128296|t=ä. Covid-19 et quelques probl�matiques �thiques en France |pdf=|usr=}}
| |
| − | {{tp|p=32387072|t=ä. COVID-19 and rhinology, from the consultation room to the operating theatre |pdf=|usr=}}
| |
| − | {{tp|p=32377857|t=ä. Nasal, pharyngeal and laryngeal endoscopy procedures during COVID-19 pandemic: available recommendations from national and international societies |pdf=|usr=}}
| |
| − | {{tp|p=32380430|t=2020. The experience on coronavirus disease 2019 and cancer from an oncology hub institution in Milan, Lombardy Region |pdf=|usr=}}
| |
| − | {{tp|p=C7136865|t=2020. Reorga" width="940" height="350" frameborder="0" scrolling="auto"> tion of medical oncology departments during the novel coronavirus disease-19 pandemic: a nationwide Italian survey |pdf=|usr=}}
| |
| − | {{tp|p=32381324|t=ä. Reorganizing Italian Internal Medicine wards for COVID 19 |pdf=|usr=}}
| |
| − | {{tp|p=32418711|t=ä. How to reduce the potential risk of vertical transmission of SARS-CoV-2 during vaginal delivery?|pdf=|usr=}}
| |
| − | {{tp|p=32382214|t=ä. Plastic surgery during the COVID-19 pandemic times |pdf=|usr=}}
| |
| − | {{tp|p=32389523|t=2020. COVID-19 and cancer: Looking for evidence |pdf=|usr=}}
| |
| − | {{tp|p=32389524|t=2020. How technology can help in oncologic patient management during COVID-19 outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32376133|t=ä. The Impact of COVID-19 on European Health Care and Urology Trainees |pdf=|usr=}}
| |
| − | {{tp|p=32414626|t=ä. Risks from Deferring Treatment for Genitourinary Cancers: A Collaborative Review to Aid Triage and Management During the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32376137|t=ä. European Association of Urology Guidelines Office Rapid Reaction Group...|pdf=|usr=}}
| |
| − | {{tp|p=32389498|t=ä. Impact of COVID-19 on Urologists: Learning on the Go |pdf=|usr=}}
| |
| − | {{tp|p=32382141|t=ä. Surgeon?s protection during ophthalmic surgery in the Covid-19 era: a novel fitted drape for ophthalmic operating microscopes |pdf=|usr=}}
| |
| − | {{tp|p=32382143|t=ä. Impact of the COVID-19 lockdown on basic science research in ophthalmology: the experience of a highly specialized research facility in France |pdf=|usr=}}
| |
| − | {{tp|p=32376977|t=ä. Changing trends of ocular trauma in the time of COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32387274|t=2020. Coronavirus disease 2019 and men?s reproductive health |pdf=|usr=}}
| |
| − | {{tp|p=32377324|t=2020. Epidemics and primary care in the UK |pdf=|usr=}}
| |
| − | {{tp|p=32387870|t=2020. Forensic medicine in the time of COVID 19: An Editorial from Milano, Italy |pdf=|usr=}}
| |
| − | {{tp|p=32387541|t=ä. SARS-CoV-2 Testing, Prevalence, and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern California |pdf=|usr=}}
| |
| − | {{tp|p=32387540|t=ä. How To Maximize Trainee Education During the COVID-19 Pandemic: Perspectives from Around the World |pdf=|usr=}}
| |
| − | {{tp|p=32356258|t=2020. Adapting a GI Fellowship to a Pandemic: Novel Approaches to Accommodating a Novel Virus |pdf=|usr=}}
| |
| − | {{tp|p=32295662|t=ä. Allocation of Scarce Resources in a Pandemic: A Systematic Review of US State Crisis Standards of Care Documents |pdf=|usr=}}
| |
| − | {{tp|p=32216085|t=2020. Travelling to scientific meetings is a mission, not a vacation |pdf=|usr=}}
| |
| − | {{tp|p=32351259|t=ä. Möglichkeiten und Grenzen von Ethikberatung im Rahmen der COVID-19-Pandemie ... |pdf=|usr=}}
| |
| − | {{tp|p=32363502|t=ä. Digital technology in psychiatry: towards the implementation of a true person-centered care in psychiatry?|pdf=|usr=}}
| |
| − | {{tp|p=32353785|t=2020. Patients with cancer in the era of 2019 novel coronavirus disease |pdf=|usr=}}
| |
| − | {{tp|p=32335477|t=2020. Cancer and coronavirus disease 2019; how do we manage cancer optimally through a public health crisis?|pdf=|usr=}}
| |
| − | {{tp|p=32333069|t=ä. No time like the present: time to re-think our habits in science and continuous medical education?|pdf=|usr=}}
| |
| − | {{tp|p=32285154|t=ä. Radioaerosols and the updated EANM guideline in ventilation/perfusion imaging |pdf=|usr=}}
| |
| − | {{tp|p=32299866|t=2020. Cancer in the time of COVID-19: expert opinion on how to adapt current practice |pdf=|usr=}}
| |
| − | {{tp|p=32349935|t=ä. Corticosteroids for Urological Cancer Care During Coronavirus Disease 2019 Treat or Not to Treat?|pdf=|usr=}}
| |
| − | {{tp|p=32345525|t=ä. Role of the Urologist During a Pandemic: Early Experience in Practicing on the Front Lines in Brooklyn, New York |pdf=|usr=}}
| |
| − | {{tp|p=32367007|t=ä. Diabetic retinopathy screening during the coronavirus disease 2019 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32350448|t=ä. Why ophthalmologists should mask: a perspective from Hong Kong |pdf=|usr=}}
| |
| − | {{tp|p=32029919|t=ä. Revisiting the dangers of the coronavirus in the ophthalmology practice |pdf=|usr=}}
| |
| − | {{tp|p=32346108|t=ä. Coronavirus disease 2019 presenting with conjunctivitis as the first symptom |pdf=|usr=}}
| |
| − | {{tp|p=32257058|t=2020. Contributions and challenges of general practitioners in China fighting against the novel coronavirus crisis |pdf=|usr=}}
| |
| − | {{tp|p=32148740|t=2020. Challenges and responsibilities of family doctors in the new global coronavirus outbreak |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | *'''[[Mental aspects of health professionals]]''' | | *'''[[Mental aspects of health professionals]]''' |
| Zeile 291: |
Zeile 182: |
| | | | |
| | *'''[[Economic aspects of the status hygienicus]]''' | | *'''[[Economic aspects of the status hygienicus]]''' |
| − | {{tp|p=32377489|t=ä. Closure of Universities Due to Coronavirus Disease 2019 (COVID-19): Impact on Education and Mental Health of Students and Academic Staff |pdf=|usr=}}
| |
| − | {{ttp|p=C7198464|t=ä. The COVID-19 Threat: An Opportunity to Rethink the European Economic Constitution and European Private Law |pdf=|usr=}}
| |
| − | {{tp|p=C7160163|t=ä. Coronavirus-Infected International Business Transactions: A Preliminary Diagnosis |pdf=|usr=}}
| |
| − | {{tp|p=C7174848|t=ä. The COVID-19 Pandemic and International Trade: Temporary Turbulence or Paradigm Shift?|pdf=|usr=}}
| |
| − |
| |
| − |
| |
| | | | |
| | | | |
| Zeile 304: |
Zeile 189: |
| | | | |
| | *'''[[Host, vector, one health, atmospheric aspects]]''' | | *'''[[Host, vector, one health, atmospheric aspects]]''' |
| − | {{tp|p=32294574|t=2020. Airborne transmission of SARS-CoV-2: The world should face the reality |pdf=|usr=}}
| |
| − | {{tp|p=C7204748|t=2020. First data analysis about possible COVID-19 virus airborne diffusion due to air particulate matter (PM): The case of Lombardy (Italy) |pdf=|usr=}}
| |
| − | {{tp|p=C7200345|t=2020. Low ambient temperatures are associated with more rapid spread of COVID-19 in the early phase of the endemic |pdf=|usr=}}
| |
| − | {{tp|p=32416359|t=2020. Decline in PM2 5 concentrations over major cities around the world associated with COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32382212|t=ä. The Environmental Impacts of the Coronavirus |pdf=|usr=}}
| |
| − | {{tp|p=32140676|t=2020. Emerging zoonoses: A one health challenge |pdf=|usr=}}
| |
| − | {{tp|p=32016718|t=ä. Synergistic China?US Ecological Research is Essential for Global Emerging Infectious Disease Preparedness |pdf=|usr=}}
| |
| − | {{tp|p=26299267|t=2015. Network analysis of host?virus communities in bats and rodents reveals determinants of cross?species transmission |pdf=|usr=}}
| |
| − | {{tp|p=32296258|t=2020. Coronavirus outbreak is a symptom of Gaia s sickness |pdf=|usr=}}
| |
| − | {{tp|p=32288964|t=2020. Animal Disease Control: Challenges and Perspectives |pdf=|usr=}}
| |
| − | {{tp|p=32247155|t=2020. Preventing bat-born viral outbreaks in future using ecological interventions |pdf=|usr=}}
| |
| − | {{tp|p=32347486|t=ä. Climatic changes and their role in emergence and re-emergence of diseases |pdf=|usr=}}
| |
| − | {{tp|p=32337677|t=ä. A research on urban eco-security evaluation and analysis: complex system?s brittle structure model |pdf=|usr=}}
| |
| − | {{ttp|p=32207922|t=ä. Environmental Engineers and Scientists Have Important Roles to Play in Stemming Outbreaks and Pandemics Caused by Enveloped Viruses |pdf=|usr=}}
| |
| − | {{tp|p=32256480|t=2020. Grand Challenge in Human/Animal Virology: Unseen, Smallest Replicative Entities Shape the Whole Globe |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| | | | |
| | | | |
| Zeile 335: |
Zeile 199: |
| | | | |
| | *'''[[Epidemiology]]''' | | *'''[[Epidemiology]]''' |
| − | {{tp|p=32371018|t=2020. Vulnerable Populations: Weathering the Pandemic Storm |pdf=|usr=}}
| |
| − | {{tp|p=32242279|t=2020. Mathematical Analysis of the Ross?Macdonald Model with Quarantine |pdf=|usr=}}
| |
| − | {{tp|p=32391077|t=2020. Simple ideas to mitigate the impacts of the COVID-19 epidemic on refugees with chronic diseases |pdf=|usr=}}
| |
| − | {{tp|p=C7155160|t=2020. The model of epidemic (COVID-19) prevention and control in rural of China |pdf=|usr=}}
| |
| − | {{tp|p=32387001|t=2020. COVID-19 and potential global mortality - Revisited |pdf=|usr=}}
| |
| − | {{tp|p=32377635|t=2020. Pandemic-related excess mortality (COVID-19), public health measures and ''funerary rituals'' |pdf=|usr=}}
| |
| − | {{tp|p=C7201017|t=2020. Facemask shortage and the novel coronavirus disease (COVID-19) outbreak: Reflections on public health measures |pdf=|usr=}}
| |
| − | {{tp|p=C7140974|t=ä. Visualising the expansion and spread of coronavirus disease 2019 by cartograms |pdf=|usr=}}
| |
| − | {{tp|p=C7200841|t=ä. Taming COVID-19 by Regulation: An Opportunity for Self-Reflection |pdf=|usr=}}
| |
| − | {{tp|p=C7156569|t=ä. Reimagining the Administrative State in Times of Global Health Crisis: An Anatomy of Taiwan?s Regulatory Actions in Response to the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32019614|t=ä. SARS to novel coronavirus ? old lessons and new lessons |pdf=|usr=}}
| |
| − | {{tp|p=15473141|t=2004. Factors associated with transmission of severe acute respiratory syndrome among health-care workers in Singapore |pdf=|usr=}}
| |
| − | {{tp|p=32352023|t=ä. Novel Coronavirus disease 2019 (COVID-19) outbreak in Nigeria: how effective are government interventions?|pdf=|usr=}}
| |
| − | {{tp|p=32307205|t=2020. Fabricated data ? should we quarantine? A novel tool for risk assessment is proposed |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| | *'''[[Remission, recurrence and persistence]]''' | | *'''[[Remission, recurrence and persistence]]''' |
| | | | |
| Zeile 356: |
Zeile 204: |
| | ---- | | ---- |
| | *'''[[Failure of politics and public health guidance]]''' | | *'''[[Failure of politics and public health guidance]]''' |
| − | {{tp|p=C7184146|t=ä. COVID-19 as a Complex Intergovernmental Problem |pdf=|usr=}}
| |
| − | {{tp|p=C7184142|t=ä. Continuity of Constitutional Government during a Pandemic: Considering the Concept in Canada s Emergency Management Act |pdf=|usr=}}
| |
| − | {{tp|p=C7167486|t=ä. Public Policy and Constitutional Rights in Times of Crisis |pdf=|usr=}}
| |
| − | {{tp|p=32309248|t=2020. Infodemic and Risk Communication in the Era of CoV-19 |pdf=|usr=}}
| |
| − | {{tp|p=C7200839|t=ä. How Risk Perceptions, Not Evidence, Have Driven Harmful Policies on COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=C7203166|t=ä. From Diversity to Coordination: A European Approach to COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=C7188958|t=ä. More Competences than You Knew? The Web of Health Competence for European Union Action in Response to the COVID-19 Outbreak |pdf=|usr=}}
| |
| − | {{tp|p=C7156563|t=ä. COVID-19, Patents and the Never-Ending Tension between Proprietary Rights and the Protection of Public Health |pdf=|usr=}}
| |
| − | {{tp|p=C7174850|t=ä. Towards Stronger EU Governance of Health Threats after the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=C7170808|t=ä. Will COVID-19 Mark the End of an Egalitarian National Health Service?|pdf=|usr=}}
| |
| − | {{tp|p=C7170810|t=ä. A Critical Appraisal of the World Health Organization?s International Health Regulations (2005) in Times of Pandemic: It Is Time for Revision |pdf=|usr=}}
| |
| − | {{tp|p=C7201134|t=ä. The UK COVID-19 Response: A Behavioural Irony?|pdf=|usr=}}
| |
| − | {{ttp|p=C7156574|t=ä. State Liability for Failure to Control the COVID-19 Epidemic: International and Dutch Law |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | | | |
| | | | |
| | *'''[[Political abuse of Covid19]]''' | | *'''[[Political abuse of Covid19]]''' |
| − | {{tp|p=C7166360|t=2015. Political Incentives to Suppress Negative Information: Evidence from Chinese Listed Firms |pdf=|usr=}}
| |
| − | {{tp|p=30972733|t=2019. Vaccines for emerging pathogens: prospects for licensure |pdf=|usr=}}
| |
| − | {{tp|p=C7180651|t=2020. To Tweet or Not to Tweet?a Review of the Viral Power of Twitter for Infectious Diseases |pdf=|usr=}}
| |
| − | {{tp|p=32368725|t=ä. Corona crisis fuels racially profiled hate in social media networks |pdf=|usr=}}
| |
| − | {{tp|p=32338736|t=ä. Twitter-based learning for continuing medical education?: A new perspective for a paradigm shift in medical education, accelerated by COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32191341|t=2020. Coronavirus disease 2019: The harms of exaggerated information and non?evidence?based measures |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| | | | |
| | | | |
| Zeile 394: |
Zeile 220: |
| | | | |
| | *'''[[History of covid19 exploration]]''' | | *'''[[History of covid19 exploration]]''' |
| − | {{tp|p=C7147143|t=2020. Zwischen Infektionsschutz und Versorgungsauftrag: Eine Zwischenbilanz vier Wochen nach Ausbruch der Pandemie |pdf=|usr=}}
| |
| − | {{tp|p=32387617|t=ä. COVID-19: The first documented coronavirus pandemic in history |pdf=|usr=}}
| |
| − | {{tp|p=32078801|t=2020. The Novel Coronavirus Outbreak: What We Know and What We Don?t |pdf=|usr=}}
| |
| − | {{tp|p=32373783|t=2020. The Italian war-like measures to fight coronavirus spreading: Re-open closed hospitals now |pdf=|usr=}}
| |
| − | {{tp|p=32322145|t=2020. The Return of the Plague: A Primer on Pandemic Ethics |pdf=|usr=}}
| |
| | | | |
| | *'''[[misc.]]''' | | *'''[[misc.]]''' |
| − | {{tp|p=C7117074|t=2020. Neuartiges Coronavirus (SARS-CoV-2) |pdf=|usr=}}
| |
| − | {{tp|p=32388105|t=2020. Distinctive cellular response to aluminum based adjuvants |pdf=|usr=}}
| |
| − | {{tp|p=C7163482|t=2020. COVID?19: Lessons from SARS and MERS |pdf=|usr=}}
| |
| − | {{tp|p=C7158301|t=2006. FERRET BEHAVIOR |pdf=|usr=}}
| |
| − | {{tp|p=32274705|t=2020. Forty Years of Basic and Translational Heparanase Research |pdf=|usr=}}
| |
| − | {{tp|p=32315610|t=2020. Exosomes as Sentinels against Bacterial Pathogens |pdf=|usr=}}
| |
| − | {{tp|p=32328964|t=ä. The shortage of skilled workers in Europe: its impact on geriatric medicine |pdf=|usr=}}
| |
| − | {{tp|p=32241833|t=ä. Will children reveal their secret? The coronavirus dilemma |pdf=|usr=}}
| |
| − | {{tp|p=31845391|t=2020. The importance of caveolins and caveolae to dermatology: Lessons from the caves and beyond |pdf=|usr=}}
| |
| − | {{tp|p=24499397|t=2014. Bacterial insertion sequences: their genomic impact and diversity |pdf=|usr=}}
| |
| − | {{tp|p=32117795|t=2020. Specific Integration of Temperate Phage Decreases the Pathogenicity of Host Bacteria |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − |
| |
| − |
| |
| | | | |
| | *'''[[Research tools]]'' | | *'''[[Research tools]]'' |
